Biochemical markers of bone metabolism: an overview (Q41696180)

7 October 2017

1 reference

title

Biochemical markers of bone metabolism: an overview (English)

1 reference

7 October 2017

Christenson RH

1

1 reference

7 October 2017

1 December 1997

1 reference

7 October 2017

Clinical Biochemistry

1 reference

7 October 2017

30

1 reference

7 October 2017

573-593

1 reference

7 October 2017

8

1 reference

Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

The structure of pyridinoline, a collagen crosslink

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Effects of endothelial cell growth factor on bone remodelling in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Isolation and characterization of insulin-like growth factor-II from human bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Gene expression during endochondral bone development: evidence for coordinate expression of transforming growth factor beta 1 and collagen type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Effect of platelet-derived growth factor on DNA and protein synthesis in cultured rat calvaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Stimulation of bone formation by prostaglandin E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Parathyroid hormone and lipopolysaccharide induce murine osteoblast-like cells to secrete a cytokine indistinguishable from granulocyte-macrophage colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Direct effects of 17 beta-estradiol on trabecular bone in ovariectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Long-term calcitonin therapy in postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Biochemical markers of bone metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Serum and urinary markers of bone remodeling: assessment of bone turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Bone-alkaline phosphatase as indicator of bone formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Biochemical markers of bone turnover: Methodology and clinical use in osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Radioimmunoassay for Human Procollagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Quantification of fetal antigen 2 (FA2) in supernatants of cultured osteoblasts, normal human serum, and serum from patients with chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Osteocalcin: diagnostic methods and clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Effect of renal function on plasma levels of bone Gla-protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Biochemical studies in the evaluation and management of osteoporosis: current status and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Serum bone gla-protein in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Comparison of monoclonal and polyclonal antibody-based immunoassays for osteocalcin: a study of sources of variation in assay results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Multiple immunoreactive forms of osteocalcin in uremic serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Serum tartrate-resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Hydroxyproline metabolism by the rat kidney: distribution of renal enzymes of hydroxyproline catabolism and renal conversion of hydroxyproline to glycine and serine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Urinary N-telopeptides to monitor bone resorption while on GnRH agonist therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Assay of pyridinium crosslinks in serum using narrow-bore ion-paired reversed-phase high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Immunoassay for urinary pyridinoline: the new marker of bone resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

New and traditional serum markers of bone metabolism in the detection of skeletal metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2897%2900113-6

10.1016/S0009-9120(97)00113-6

7 January 2021

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

9455610